Takeovers Panel states no objection to Metlifecare scheme

Metlifecare Limited (NZX: MET , ASX: MEQ) confirms that the Takeovers Panel has advised it intends to provide Metlifecare with a ‘no objection’ statement with respect to the Scheme of Arrangement (Scheme) with Asia Pacific Village Group Limited (APVG) later today.

The decision means the Scheme will shortly meet another key condition required for it to proceed.

The Scheme remains subject to the High Court issuing final orders, with a hearing scheduled for Tuesday 20 October 2020. In the event that final Court orders are granted in the middle of this week, the implementation date would be 3 November 2020.

Metlifecare shareholders do not need to take any further action at this stage.

This announcement is authorised for release to the market by the Company Secretary

Source: Metlifecare Limited (NZX: MET , ASX: MEQ)

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

PEB - Cash Burn Slows; Coverage Catalysts in Focus
SKYCITY REACHES AGREEMENT TO SETTLE NZ AML/CFT PROCEEDINGS
Infratil Full Year Results for the year ended 31 March 2024
May 21st Morning Report
Manawa Energy FY24 results: Solid result driven by strong asset management and focus on strategy and value creation
Devon Funds Morning Note - 20 May 2024
EXPRESSION OF INTEREST IN THE SUPPLY OF MEREENIE GAS
IPL - FY24 Annual Results
CEN - Contact to revisit Wairākei development options
May 17th Morning Report